Howard Rossman

961 total citations
9 papers, 403 citations indexed

About

Howard Rossman is a scholar working on Pathology and Forensic Medicine, Neurology and Sensory Systems. According to data from OpenAlex, Howard Rossman has authored 9 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 3 papers in Sensory Systems. Recurrent topics in Howard Rossman's work include Multiple Sclerosis Research Studies (6 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Olfactory and Sensory Function Studies (3 papers). Howard Rossman is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Olfactory and Sensory Function Studies (3 papers). Howard Rossman collaborates with scholars based in United States, United Kingdom and Netherlands. Howard Rossman's co-authors include Heidi Crayton, Rock Heyman, Fiona Forrestal, Marianne T. Sweetser, Michael D. Kaufman, Gabriel Pardo, Petra W. Duda, Klaus Schmierer, Omar Khan and David H. Miller and has published in prestigious journals such as Neurology, Journal of the Neurological Sciences and Clinical Therapeutics.

In The Last Decade

Howard Rossman

9 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard Rossman United States 7 336 111 84 66 54 9 403
Katelyn Kavak United States 12 369 1.1× 120 1.1× 66 0.8× 68 1.0× 70 1.3× 32 506
Alexander Stahmann Germany 12 315 0.9× 108 1.0× 62 0.7× 30 0.5× 67 1.2× 38 395
Amy Perrin Ross United States 12 265 0.8× 76 0.7× 59 0.7× 66 1.0× 61 1.1× 35 425
Salvatore Cottone Italy 9 199 0.6× 102 0.9× 54 0.6× 28 0.4× 47 0.9× 24 333
Alice Rutatangwa United States 11 267 0.8× 103 0.9× 47 0.6× 125 1.9× 32 0.6× 14 400
Reza Vosoughi Canada 9 194 0.6× 107 1.0× 36 0.4× 62 0.9× 55 1.0× 22 354
Fereshteh Ashtari Iran 11 335 1.0× 239 2.2× 27 0.3× 56 0.8× 64 1.2× 53 487
Sonu M. Brara United States 8 436 1.3× 152 1.4× 53 0.6× 117 1.8× 98 1.8× 11 667
Marguerite Duggan Ireland 11 285 0.8× 64 0.6× 39 0.5× 27 0.4× 60 1.1× 14 350
Edlin Gonzales United States 11 247 0.7× 79 0.7× 56 0.7× 128 1.9× 31 0.6× 15 428

Countries citing papers authored by Howard Rossman

Since Specialization
Citations

This map shows the geographic impact of Howard Rossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Rossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Rossman more than expected).

Fields of papers citing papers by Howard Rossman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Rossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Rossman. The network helps show where Howard Rossman may publish in the future.

Co-authorship network of co-authors of Howard Rossman

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Rossman. A scholar is included among the top collaborators of Howard Rossman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Rossman. Howard Rossman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Cadavid, Diego, Keith R. Edwards, Raymond Hupperts, et al.. (2015). BIIB033, Anti-LINGO-1 Antibody, for Treatment of Relapsing Forms of Multiple Sclerosis: Baseline Data of the Phase 2 SYNERGY Trial (P7.204). Neurology. 84(14_supplement). 4 indexed citations
2.
Kaufman, Michael D., Gabriel Pardo, Howard Rossman, et al.. (2014). Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis. Journal of the Neurological Sciences. 341(1-2). 22–27. 61 indexed citations
3.
Goodman, Andrew, Howard Rossman, Amit Bar‐Or, et al.. (2009). GLANCE. Neurology. 72(9). 806–812. 99 indexed citations
4.
Collins, Robert H., et al.. (2008). Mitoxantrone-Associated Leukemia in Multiple Sclerosis: Case Studies. International Journal of MS Care. 10(2). 41–46. 7 indexed citations
5.
Wilken, Jeffrey, Mitchell T. Wallin, Catherine H. Rogers, et al.. (2008). Treatment of Multiple Sclerosis–Related Cognitive Problems With Adjunctive Modafinil. International Journal of MS Care. 10(1). 1–10. 11 indexed citations
6.
Crayton, Heidi & Howard Rossman. (2006). Managing the symptoms of multiple sclerosis: A multimodal approach. Clinical Therapeutics. 28(4). 445–460. 113 indexed citations
7.
Rossman, Howard, et al.. (2005). Setting Up a Neurology-Based Infusion Center: Rationale and Guidelines. 2 indexed citations
8.
Rossman, Howard. (2004). Neutralizing antibodies to multiple sclerosis treatments.. PubMed. 10(3 Suppl B). S12–9. 9 indexed citations
9.
Crayton, Heidi, Rock Heyman, & Howard Rossman. (2004). A multimodal approach to managing the symptoms of multiple sclerosis. Neurology. 63(11_suppl_5). S12–8. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026